Cathie Wood’s ARK sells AMD stock, buys Kratos and Tempus AI

ARK published Monday, May 11, 2026 trades showing a $17.2M sale of 37,836 AMD shares, alongside major buys in Kratos Defense ($10.6M), Tempus AI ($8.1M), Circle Internet ($4.8M), and Natera ($6.0M). The activity signals continued rotation out of AMD and several biotech names, while adding to defense, AI, and crypto-linked positions. The article is mainly a flow/positioning update and is unlikely to move broad markets, though it may affect the named stocks modestly.

Analysis

The flow pattern says more about factor rotation than stock-specific conviction. ARK is increasing exposure to defense, AI infrastructure, and digital assets while trimming legacy high-beta semis and select genomics tools, which is consistent with a regime where investors still want upside but are becoming more selective about cash burn, revenue quality, and path-to-scale. The market implication is that names with credible near-term monetization and contract-backed revenue should keep attracting incremental flows, while “story” exposure with crowded ownership becomes more vulnerable to de-rating on any disappointment.

KTOS stands out as the cleanest beneficiary because defense spending has a longer duration than the current attention cycle and its business model is less exposed to valuation compression if rates stay sticky. The second-order effect is that capital can rotate from space/speculative hardware into firms that can actually convert geopolitical tension into booked demand; that should also support adjacent primes and drone/autonomy suppliers not named here. By contrast, RKLB and TWST look like classic liquidity-proxy names: when growth sentiment wobbles, they can underperform even without fundamental deterioration.

TEM is the highest-quality momentum expression in the group, but it is also the most vulnerable to crowded positioning if the market shifts from “AI optionality” to “earnings proof.” If the next 1-2 quarters show continued commercial traction, the multiple can remain elevated; if not, the stock likely trades more like a software-duration name than a healthcare compounder. CRCL and NTRA add a digital-asset/diagnostics tilt, but the real read-through is that ARK is prioritizing categories where data-network effects or regulatory moats can expand margins over time.

The contrarian angle is that this may be less a bullish call on the buys than an implicit admission that the sold names have become less resilient in a higher-for-longer macro. AMD and the biotechnology cutters may be facing the same problem: excellent long-term stories, but not enough near-term catalysts to justify premium ownership when flows are discriminating. That makes the next 30-60 days a positioning window, not a fundamentals window, and reversals will likely come from earnings surprises or a broad risk-on squeeze rather than incremental narrative support.

Key Decisions for Investors

• Go long KTOS over the next 2-4 weeks into any defense-sector dip; risk/reward favors continuation if geopolitical headlines keep defense procurement in focus. Stop if it loses relative strength versus XAR for 3 consecutive sessions.
• Pair trade: long TEM / short TWST for a 1-3 month horizon. TEM has clearer monetization torque from AI-led demand, while TWST is more exposed to funding-cycle compression; target 1.5:1 upside/downside with the short as a hedge on genomics beta.
• Reduce or hedge AMD exposure via call overwrites or short-dated puts into earnings/pre-earnings rallies. The name still has secular value, but ARK-style distribution often precedes a period of multiple compression when momentum buyers step away.
• Speculative long NTRA vs CDNA as a quality-biased diagnostics spread over 1-2 quarters. NTRA has better operating leverage and should be more resilient if healthcare sentiment stays mixed; CDNA looks more vulnerable to flow-driven underperformance.
• Treat RKLB as a tactical short on strength for 2-6 weeks, especially if retail flow remains crowded. The setup works best if broader small-cap growth weakens; cover into any space-news-driven spike.